Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
save 25 %
* Required Fields
Pay by invoice
This edition of the Drug Discovery TOE depicts trends across orphan drugs in North America. Compared with standard drugs, orphan drugs involve fewer clinical trial issues. Typically, orphan drugs spend less time in regulatory review, comprise smaller phase III trial sizes, and are more likely to be approved by the US Food and Drug Administration (FDA) because they represent significant therapeutic advances for really unsolved problems. This and the higher chance of FDA approval makes many companies to penetrate the market. However, innovation is critical. Strategic partnerships and tactical regulatory planning that allow for optimizing budgets and exploiting research and clinical expertise are crucial for development success. Some companies innovating in this field and the patent scenario are depicted in this TOE.The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Orphan drugs, rare diseases, genetic diseases, clinical trials, fast-track designation, breakthrough therapy designation, lysosomal storage disorders, post-transcriptional control processes, synthetic retinoid products
Global Orthopedics Growth Opportunities
GROWTH OPPORTUNITIES IN SYNTHETIC BIOLOGY, AI AUGMENTED DIAGNOSTICS, MICROBIOME ENABLERS, BIOMARKER DISCOVERY, AND LAB AUTOMATION
US Chronic Disease Management Growth Opportunities
Global Neurological Therapies Growth Opportunities
Global Structural Heart Devices Growth Opportunities
Global Healthcare Cloud Growth Opportunities
INNOVATIONS AND GROWTH OPPORTUNITIES IN ORGAN PERFUSION AND PRESERVATION, DIGITAL THERAPEUTICS, AND WOUND ANALYSIS PLATFORMS
GROWTH OPPORTUNITIES IN PLATFORM TECHNOLOGIES, DIAGNOSTICS, AND ADVANCED THERAPEUTICS
Global Renal Care Management Growth Opportunities
cloud security market
aerospace industry outlook
nutritional supplement market
alternative energy market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.